Paris Basketball and ThermoHuman have reached a partnership agreement to integrate infrared thermography technology into the protocols of their health and performance department. The main objective of this new strategic alliance is to optimize the physical preparation and recovery of the Parisian first team ahead of the demanding challenges of the season, both in the domestic league (LNB Pro A) and in European competition.

The demanding schedule of elite basketball requires exhaustive monitoring of the players' physical condition. The incredibly high frequency of games, constant travel, and current competitive density demand monitoring tools that are precise, agile, and effective to keep the team at its peak level.

To respond to this need, Paris Basketball has incorporated ThermoHuman technology. Through the use of thermal cameras and our advanced Artificial Intelligence-based software, the French team will be able to quickly, objectively, and non-invasively evaluate their athletes' physiological response to the tremendous competitive stress on the court.

The implementation of thermography in the club's daily routine will allow its coaching and medical staff to:

• Monitor effort assimilation: Early identification of body and joint areas with greater metabolic stress resulting from training sessions and games.
• Evaluate and personalize recovery: Objectively analyzing the thermal evolution of each player to measure the effectiveness of rest strategies and apply the most appropriate physiotherapy treatments.
• Individualize physical work: Providing quantitative metrics that facilitate decision-making and the proactive adjustment of training sessions to the specific needs and real status of each basketball player.

For ThermoHuman, it is a true privilege to start working alongside such an ambitious and internationally growing project as Paris Basketball. This partnership reinforces our commitment to applying cutting-edge technology and data analysis to maximize sports performance in the elite of European basketball.